AstraZeneca buys Hamilton-based smart cancer drug maker Fusion Pharmaceuticals for $2-billion - The Globe and Mail

AstraZeneca buys Hamilton-based smart cancer drug maker Fusion Pharmaceuticals for $2-billion  The Globe and Mail